Supplementary Table 1.docx (40.79 kB)
Download fileSupplementary Table 1: Preclinical studies conducted on nanozyme antioxidants: shortcomings and challenges based on US FDA regulations.docx
dataset
posted on 11.05.2021, 13:14 authored by Milad Ghorbani, Zhila Izadi, Samira Jafari, Eudald Casals, Foroogh Rezaei, Alireza Aliabadi, Alycia Moore, Ali Ansari, Víctor Puntes, Mehdi Jaymand, Hossein Derakhshankhah
Table S1. An overview on the results of the papers which have conducted in vivo analysis for evaluation of nanozyme antioxidants since 2009. |